Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon granted inducement awards to seven new non-officer employees, totaling 25,600 options and 15,000 RSUs approved by the Compensation Committee on April 30. The options were granted at the money with an exercise price of $56.04, equal to the closing price on the grant date.
Key figures
- Grant date
- April 30, 2026
- Rsus granted
- 15000
- Exercise price
- $56.04
- Options granted
- 25600
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.